Detalles de la búsqueda
1.
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial.
Br J Cancer
; 119(2): 170-175, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29961759
2.
Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.
Ann Surg Oncol
; 22 Suppl 3: S905-14, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26001861
3.
Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation.
Gastric Cancer
; 18(2): 314-25, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24722800
4.
Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor.
Langenbecks Arch Surg
; 398(2): 239-49, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23269519
5.
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial.
BMC Cancer
; 12: 108, 2012 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22439666
6.
Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).
BMC Cancer
; 12: 142, 2012 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22480173
7.
Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
BMC Cancer
; 11: 266, 2011 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21702914
8.
Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction.
J Gastrointestin Liver Dis
; 22(1): 45-52, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23539390
Resultados
1 -
8
de 8
1
Próxima >
>>